Stanford Investment Group’s Chemours CC Stock Holding History

Stanford Investment Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5	Closed	–	–	378
2016 Q3	$0	Buy	+5	New	+$57	﹤0.01%	408

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Stanford Investment Group's CC Position: Q4 2016 in Review

Stanford Investment Group sold out of Chemours (CC) in Q4 2016, closing a stake of 5 shares.

Stanford Investment Group first reported a position in CC in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 417 funds tracked by Wall St. Rank hold CC as of Q4 2016.

Stanford Investment Group reported no remaining Chemours position as of Q4 2016 after selling out during the quarter.
Stanford Investment Group sold 5 Chemours shares in Q4 2016.
Stanford Investment Group first reported a position in Chemours in Q3 2016 and held it in 1 quarter.
Stanford Investment Group's Chemours position peaked at $0 in Q3 2016.
417 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on Stanford Investment Group's 13F filing for Q4 2016, filed 2 Feb 2017.